Laboratory Corporation of America Holdings (0JSY.L)
USD 225.47
(2.86%)
USD 225.47
(2.86%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.34 Billion USD | -37.86% |
| 2022 | 1.95 Billion USD | -33.36% |
| 2021 | 4.27 Billion USD | 16.17% |
| 2020 | 3.25 Billion USD | 80.01% |
| 2019 | 2.11 Billion USD | -6.49% |
| 2018 | 2.06 Billion USD | 6.75% |
| 2017 | 1.84 Billion USD | 4.87% |
| 2016 | 1.8 Billion USD | 19.26% |
| 2015 | 1.57 Billion USD | 31.58% |
| 2014 | 1.17 Billion USD | 7.63% |
| 2013 | 1.23 Billion USD | -3.12% |
| 2012 | 1.25 Billion USD | 2.08% |
| 2011 | 1.18 Billion USD | 4.72% |
| 2010 | 1.18 Billion USD | 4.65% |
| 2009 | 1.14 Billion USD | 13.6% |
| 2008 | 1.03 Billion USD | -12.79% |
| 2007 | 990.4 Million USD | 22.11% |
| 2006 | 853.1 Million USD | 5.75% |
| 2005 | 784.8 Million USD | 9.45% |
| 2004 | 790.2 Million USD | 9.77% |
| 2003 | 668.4 Million USD | 16.77% |
| 2002 | 554.3 Million USD | 19.27% |
| 2001 | 471.6 Million USD | 39.63% |
| 2000 | 339.7 Million USD | 45.14% |
| 1999 | 234.2 Million USD | 13.19% |
| 1998 | 211.8 Million USD | 2852.63% |
| 1997 | 17.5 Million USD | -180.0% |
| 1996 | 186.7 Million USD | -93.13% |
| 1995 | 139.6 Million USD | -20.71% |
| 1994 | 154.3 Million USD | -13.37% |
| 1993 | 217.7 Million USD | -44.24% |
| 1992 | 227 Million USD | 80.67% |
| 1991 | 195.5 Million USD | 23.11% |
| 1990 | 158.8 Million USD | 25.93% |
| 1989 | 126.1 Million USD | -59.83% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 463.3 Million USD | -2.97% |
| 2024 Q2 | 422.5 Million USD | -8.81% |
| 2023 Q3 | 375.7 Million USD | -13.97% |
| 2023 Q2 | 436.7 Million USD | 6.07% |
| 2023 Q1 | 411.7 Million USD | -18.15% |
| 2023 Q4 | 483.3 Million USD | 28.64% |
| 2023 FY | - USD | -37.86% |
| 2022 FY | - USD | -33.36% |
| 2022 Q1 | 720.4 Million USD | -15.89% |
| 2022 Q2 | 636 Million USD | -11.72% |
| 2022 Q3 | 530.3 Million USD | -16.62% |
| 2022 Q4 | 503 Million USD | -5.15% |
| 2021 Q1 | 922.9 Million USD | -27.39% |
| 2021 Q2 | 999.8 Million USD | 8.33% |
| 2021 Q3 | 923 Million USD | -7.68% |
| 2021 Q4 | 856.5 Million USD | -7.2% |
| 2021 FY | - USD | 16.17% |
| 2020 FY | - USD | 80.01% |
| 2020 Q3 | 1.47 Billion USD | 25.14% |
| 2020 Q2 | 1.17 Billion USD | 136.94% |
| 2020 Q4 | 1.27 Billion USD | -13.84% |
| 2020 Q1 | 497.5 Million USD | 26.88% |
| 2019 Q3 | 515.3 Million USD | 2.34% |
| 2019 Q4 | 392.1 Million USD | -23.91% |
| 2019 FY | - USD | -6.49% |
| 2019 Q1 | 551.4 Million USD | 4.06% |
| 2019 Q2 | 503.5 Million USD | -8.69% |
| 2018 Q2 | 699.3 Million USD | 33.02% |
| 2018 FY | - USD | 6.75% |
| 2018 Q4 | 529.9 Million USD | 26.56% |
| 2018 Q3 | 418.7 Million USD | -40.13% |
| 2018 Q1 | 525.7 Million USD | 13.91% |
| 2017 Q4 | 461.5 Million USD | -9.05% |
| 2017 FY | - USD | 4.87% |
| 2017 Q1 | 505.8 Million USD | 9.06% |
| 2017 Q3 | 507.4 Million USD | 2.51% |
| 2017 Q2 | 495 Million USD | -2.14% |
| 2016 FY | - USD | 19.26% |
| 2016 Q2 | 464.9 Million USD | -6.72% |
| 2016 Q4 | 463.8 Million USD | -1.19% |
| 2016 Q3 | 469.4 Million USD | 0.97% |
| 2016 Q1 | 498.4 Million USD | 10.36% |
| 2015 Q3 | 409.7 Million USD | -9.68% |
| 2015 FY | - USD | 31.58% |
| 2015 Q4 | 451.6 Million USD | 10.23% |
| 2015 Q1 | 455.4 Million USD | 76.51% |
| 2015 Q2 | 453.6 Million USD | -0.4% |
| 2014 Q2 | 308.9 Million USD | -4.28% |
| 2014 Q1 | 322.7 Million USD | 33.46% |
| 2014 Q3 | 285.3 Million USD | -7.64% |
| 2014 FY | - USD | 7.63% |
| 2014 Q4 | 258 Million USD | -9.57% |
| 2013 Q2 | 276.9 Million USD | -7.7% |
| 2013 FY | - USD | -3.12% |
| 2013 Q4 | 241.8 Million USD | -0.82% |
| 2013 Q1 | 300 Million USD | 2.49% |
| 2013 Q3 | 243.8 Million USD | -11.95% |
| 2012 Q4 | 292.7 Million USD | 11.42% |
| 2012 FY | - USD | 2.08% |
| 2012 Q3 | 262.7 Million USD | -4.96% |
| 2012 Q2 | 276.4 Million USD | -10.32% |
| 2012 Q1 | 308.2 Million USD | -0.39% |
| 2011 Q4 | 309.4 Million USD | -2.95% |
| 2011 FY | - USD | 4.72% |
| 2011 Q3 | 318.8 Million USD | 10.93% |
| 2011 Q1 | 268.3 Million USD | -6.65% |
| 2011 Q2 | 287.4 Million USD | 7.12% |
| 2010 Q3 | 288.8 Million USD | 10.36% |
| 2010 FY | - USD | 4.65% |
| 2010 Q4 | 287.4 Million USD | -0.48% |
| 2010 Q1 | 293 Million USD | 10.57% |
| 2010 Q2 | 261.7 Million USD | -10.68% |
| 2009 FY | - USD | 13.6% |
| 2009 Q4 | 265 Million USD | -2.68% |
| 2009 Q3 | 272.3 Million USD | 6.66% |
| 2009 Q2 | 255.3 Million USD | -6.96% |
| 2009 Q1 | 274.4 Million USD | -5.7% |
| 2008 FY | - USD | -12.79% |
| 2008 Q4 | 291 Million USD | 37.98% |
| 2008 Q1 | 272.1 Million USD | -4.43% |
| 2008 Q2 | 282 Million USD | 3.64% |
| 2008 Q3 | 210.9 Million USD | -25.21% |
| 2007 Q3 | 247.2 Million USD | -12.31% |
| 2007 FY | - USD | 22.11% |
| 2007 Q1 | 266.2 Million USD | 10.14% |
| 2007 Q2 | 281.9 Million USD | 5.9% |
| 2007 Q4 | 284.7 Million USD | 15.17% |
| 2006 FY | - USD | 5.75% |
| 2006 Q4 | 241.7 Million USD | 21.03% |
| 2006 Q3 | 199.7 Million USD | -6.59% |
| 2006 Q2 | 213.8 Million USD | -6.35% |
| 2006 Q1 | 228.3 Million USD | 10.08% |
| 2005 Q3 | 187.9 Million USD | -10.01% |
| 2005 Q2 | 208.8 Million USD | -2.06% |
| 2005 Q4 | 207.4 Million USD | 10.38% |
| 2005 Q1 | 213.2 Million USD | 10.41% |
| 2005 FY | - USD | 9.45% |
| 2004 Q2 | 187.8 Million USD | -6.15% |
| 2004 FY | - USD | 9.77% |
| 2004 Q4 | 193.1 Million USD | 15.08% |
| 2004 Q1 | 200.1 Million USD | 11.85% |
| 2004 Q3 | 167.8 Million USD | -10.65% |
| 2003 Q1 | 176.5 Million USD | 11.91% |
| 2003 Q3 | 163.6 Million USD | -8.11% |
| 2003 Q2 | 172.9 Million USD | -0.17% |
| 2003 FY | - USD | 16.77% |
| 2003 Q4 | 178.8 Million USD | 10.36% |
| 2002 Q2 | 140.3 Million USD | -3.52% |
| 2002 Q1 | 157.6 Million USD | 12.78% |
| 2002 Q3 | 117.7 Million USD | -15.73% |
| 2002 Q4 | 157.8 Million USD | 24.33% |
| 2002 FY | - USD | 19.27% |
| 2001 FY | - USD | 39.63% |
| 2001 Q4 | 138.7 Million USD | 32.03% |
| 2001 Q3 | 105.9 Million USD | -22.64% |
| 2001 Q1 | 128.8 Million USD | 17.04% |
| 2001 Q2 | 126 Million USD | 5.03% |
| 2000 Q4 | 110.9 Million USD | 41.41% |
| 2000 Q1 | 94.2 Million USD | 21.32% |
| 2000 FY | - USD | 45.14% |
| 2000 Q2 | 93.2 Million USD | -3.45% |
| 2000 Q3 | 73.8 Million USD | -15.49% |
| 1999 Q2 | 60.5 Million USD | -1.42% |
| 1999 FY | - USD | 13.19% |
| 1999 Q4 | 78.9 Million USD | 44.85% |
| 1999 Q3 | 54.6 Million USD | -12.82% |
| 1999 Q1 | 63.5 Million USD | 11.64% |
| 1998 Q3 | 47.9 Million USD | -11.25% |
| 1998 Q2 | 54.5 Million USD | -7.67% |
| 1998 Q4 | 55.6 Million USD | 17.88% |
| 1998 Q1 | 58.8 Million USD | 20.78% |
| 1998 FY | - USD | 2852.63% |
| 1997 Q1 | 52.8 Million USD | 6.75% |
| 1997 FY | - USD | -180.0% |
| 1997 Q4 | 50.7 Million USD | 131.17% |
| 1997 Q3 | -155.4 Million USD | -429.6% |
| 1997 Q2 | 47.8 Million USD | -9.39% |
| 1996 Q1 | 41.7 Million USD | 34.66% |
| 1996 FY | - USD | -93.13% |
| 1996 Q4 | 49.7 Million USD | 114.92% |
| 1996 Q3 | -142.1 Million USD | -245.75% |
| 1996 Q2 | 40.5 Million USD | 248.68% |
| 1995 Q2 | 62.6 Million USD | -54.93% |
| 1995 Q4 | 48.6 Million USD | 142.58% |
| 1995 Q1 | 63.3 Million USD | 173.27% |
| 1995 FY | - USD | -20.71% |
| 1995 Q3 | -37.2 Million USD | -280.87% |
| 1994 Q4 | 50.9 Million USD | 33.95% |
| 1994 Q2 | 47.8 Million USD | 70.65% |
| 1994 Q1 | 40.5 Million USD | 44.6% |
| 1994 FY | - USD | -13.37% |
| 1994 Q3 | 38 Million USD | -45.04% |
| 1993 Q1 | 66.2 Million USD | 0.3% |
| 1993 Q4 | 28 Million USD | 24.11% |
| 1993 Q3 | 22.6 Million USD | -52.64% |
| 1993 Q2 | 62.9 Million USD | -28.22% |
| 1993 FY | - USD | -44.24% |
| 1992 Q3 | 47.9 Million USD | 183.36% |
| 1992 Q1 | 59 Million USD | -1.0% |
| 1992 Q2 | 59.8 Million USD | 3.69% |
| 1992 FY | - USD | 80.67% |
| 1992 Q4 | 66.1 Million USD | -62.54% |
| 1991 Q4 | 58.2 Million USD | -2.9% |
| 1991 FY | - USD | 23.2% |
| 1991 Q2 | 46.9 Million USD | -3.97% |
| 1991 Q3 | 55.4 Million USD | 35.29% |
| 1991 Q1 | 48.6 Million USD | 8.88% |
| 1990 Q4 | 44.6 Million USD | -14.42% |
| 1990 Q2 | 36.9 Million USD | -5.0% |
| 1990 FY | - USD | 23.65% |
| 1990 Q1 | 39.6 Million USD | 3.54% |
| 1990 Q3 | 44.7 Million USD | 42.11% |
| 1989 Q3 | 36.8 Million USD | 28.22% |
| 1989 FY | - USD | -58.24% |
| 1989 Q4 | 37.6 Million USD | -0.27% |
| 1989 Q1 | 31.3 Million USD | 7.19% |
| 1989 Q2 | 28.7 Million USD | -8.31% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 1410.797% |
| Accuray Incorporated | 9 Million USD | -14878.355% |
| Align Technology, Inc. | 799.03 Million USD | -68.878% |
| Elevance Health Inc. | 10.49 Billion USD | 87.136% |
| AxoGen, Inc. | -13.32 Million USD | 10224.55% |
| Boston Scientific Corporation | 3.61 Billion USD | 62.652% |
| CVS Health Corporation | 18.17 Billion USD | 92.577% |
| Cardinal Health, Inc. | 1.97 Billion USD | 31.78% |
| Centene Corporation | -463 Million USD | 391.447% |
| DaVita Inc. | 2.34 Billion USD | 42.492% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 89.392% |
| Hologic, Inc. | 1.29 Billion USD | -4.104% |
| Humana Inc. | -561 Million USD | 340.535% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | -10.819% |
| Masimo Corporation | 236.7 Million USD | -470.089% |
| McKesson Corporation | 4.66 Billion USD | 71.086% |
| Patterson Companies, Inc. | 374.75 Million USD | -260.074% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | 22.09% |
| ResMed Inc. | 1.6 Billion USD | 15.68% |
| Henry Schein, Inc. | 943 Million USD | -43.097% |
| Teladoc Health, Inc. | 153.99 Million USD | -776.251% |
| Universal Health Services, Inc. | 1.74 Billion USD | 22.6% |
| Veeva Systems Inc. | 429.33 Million USD | -214.301% |
| Baxter International Inc. | 2.77 Billion USD | 51.39% |
| Becton, Dickinson and Company | 4.27 Billion USD | 68.435% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 43.636% |
| Danaher Corporation | 7.49 Billion USD | 82.006% |
| Stryker Corporation | 5.16 Billion USD | 73.849% |
| Medtronic plc | 9.05 Billion USD | 85.099% |